Crowdfunding
Exit for Kippy, which Had Closed Two Equity Crowdfunding Rounds
Kippy recently participated in the third batch of the A-Road acceleration and fundraising program which, through ongoing training and mentorship activities and ad hoc professional services, supported the company on its growth path. And, last December, it raised a €2.6 million investment round, which had been led by Oltre III, the third fund launched by Oltre Impact sgr spa – EuVeca.
Datamars, a leading global provider of identification and data management solutions for the pet, livestock, and textile markets, announced that it has acquired Kippy Srl.
This is an Italian pet care scaleup that develops and manufactures IOT devices that can locate and monitor pet health, as a natural expansion of its offering to pet owners globally.
Read more about Kippy and find the most important financial news of the day with our companion app born2Invest.
The exit of the Italian scaleup Kippy
The deal was coordinated by Growth Capital, a leading advisor in extraordinary finance transactions for startups and scaleups, as the sole financial advisor for Kippy.
With this partnership, Datamars strengthens its market-leading location and reunification solution, which has helped identify more than 50 million pets and reunite thousands of lost animals with their owners.
“As pet ownership increases in all major global markets, so does the demand for products and services to keep these beloved family members happy, healthy, and safe. I am excited to partner with Kippy to bring the best of our technologies to more pet owners around the world,” said Daniele Della Libera, CEO of Datamars.
Two successful campaigns on Mamacrowd
Milan-based Kippy was founded in 2013 by friends and co-CEOs Marco Brunetti and Simone Sangiorgi, who will join Datamars, along with all Kippy team members, to continue developing the pet tracking and monitoring business.
Kippy recently participated in the third batch of the A-Road acceleration and fundraising program which, through ongoing training and mentorship activities and ad hoc professional services, supported the company on its growth path.
And, last December, it raised a €2.6 million investment round, which had been led by Oltre III, the third fund launched by Oltre Impact sgr spa – EuVeca, Italy’s leading impact investor. Business angel Fabio de Concilio, the founder of Farmacosmo, also participated in the round.
Previously, Kippy had closed two equity crowdfunding rounds on Mamacrowd. The most recent, in 2021, had raised €1.16 million from 87 investors including Azimut Libera Impresa (lead investor), with a pre-money valuation of €9.5 million.
In 2019, Kippy closed its first campaign by raising €1.14 million from 242 investors, with a pre-money valuation of €6 million.
“We are proud to have supported Marco and Simone from the first investment rounds to the exit phase, supporting Kippy in the growth of the business and its consolidation in the market culminating in the merger and partnership phase with Datamars,” concludes Andrea Casati, vice president of Growth Capital.
International development
Kippy’s GPS-enabled collar device tracks the activity and location of the animal in real-time and provides detailed information and reports directly to dog and cat owners through a smartphone app.
In addition to providing the ability to geolocate, owners can thus easily check whether their pet is getting enough physical activity. Kippy is also one of the few solutions on the market that combines GPS tracking with communication and engagement features, such as personalized messaging and a dedicated social network within the app.
“We have enjoyed great success in Europe and have developed a strong and satisfied customer base of pet owners. By joining Datamars we are now in a position to take the next step to further grow Kippy and expand into other markets. Datamars’ strong presence in North America, Latin America, Australia, and New Zealand, as well as Europe, combined with their global manufacturing, logistics presence, and product development, will allow us to continue to invest in and evolve Kippy’s offerings and bring these great products to even more pets and their respective owners around the world,” said Marco Brunetti and Simone Sangiorgi, Co-CEOs of Kippy.
Kippy will thus represent a significant part of Datamars’ dedicated pet ecosystem, extending from identification to health and activity monitoring to reunification solutions, enabled and supported by a digital customer environment and support services.
Datamars is controlled by Caisse de Dépôt et Placement du Québec (CDPQ), which in 2017 joined Columna Capital, an investor since 2011, in the company’s capital, while in 2021 Indigo Capital also joined the capital with a minority stake.
__
(Featured image by AnjaGh via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Rovi Cuts Its Profit by 4% in the First Nine Months, to 113.5 Million
-
Biotech4 days ago
Better Care Advances Healthcare Technology with Partnership with Oracle
-
Fintech1 week ago
Fintech Company Satispay Raises 60 Million Euros Led by Addition
-
Biotech2 days ago
ATB Therapeutics Raises €54 Million and Attracts a Pharmaceutical Giant